Trials / Sponsors / Marina Kremyanskaya
Marina Kremyanskaya
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm Myelofibrosis, Essential Thrombocythemia, MPN | Phase 1 | 2023-04-04 |
| Withdrawn | Ruxolitinib in Combination With Autotransplant Myelofibrosis, MF | N/A | 2015-05-01 |